NasdaqGS - Delayed Quote USD

Unity Biotechnology, Inc. (UBX)

Compare
1.1500 -0.0600 (-4.96%)
At close: November 6 at 4:00 PM EST
1.1501 +0.00 (+0.01%)
After hours: 7:49 PM EST
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-22,535.0000
-37,088.0000
-52,414.0000
-45,060.0000
-78,333.0000
Investing Cash Flow
19,101.0000
60,495.0000
-24,545.0000
39,313.0000
-5,208.0000
Financing Cash Flow
4,456.0000
-16,340.0000
56,240.0000
20,845.0000
63,875.0000
End Cash Position
9,794.0000
20,699.0000
13,632.0000
34,351.0000
19,253.0000
Interest Paid Supplemental Data
--
1,969.0000
2,204.0000
2,370.0000
773.0000
Capital Expenditure
-66.0000
-11.0000
-96.0000
-195.0000
-646.0000
Issuance of Capital Stock
4,363.0000
5,107.0000
58,065.0000
18,572.0000
37,270.0000
Issuance of Debt
--
--
--
--
24,550.0000
Repayment of Debt
--
-20,000.0000
--
-68.0000
-405.0000
Free Cash Flow
-22,535.0000
-37,099.0000
-52,510.0000
-45,255.0000
-78,979.0000
12/31/2020 - 5/3/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers